Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care
Newsroom
News
Press Releases Stanford Health Care in the News Other News Patient Stories Videos
For Reporters
Media Contacts Patient Privacy Policies
Newsroom
News
Press Releases Stanford Health Care in the News Other News Patient Stories Videos
For Reporters
Media Contacts Patient Privacy Policies
Download PDF
Please enter your email address in order to download the file.

EMAIL
Why do we need this?

We will use your email address for internal purposes only. See our Privacy Policies for more information.

Thank you for entering your email address.

The file will automatically download.

Press Release

Stanford Medicine researchers lead clinical trial of interferon-lambda for COVID-19

May 21, 2020

Scientists at Stanford Medicine are investigating whether a molecule called interferon-lambda can help people with mild cases of COVID-19 feel better and reduce their transmission of the disease-causing virus.

By BRUCE GOLDMAN

Related Topics

New Stanford Hospital
Close